Schweizer Zeitschrift für Dermatologie & Ästhetische Medizin [medicos] 02/2017

Hyperhidrosis is a rare disease usually starting in childhood or adolescence, localized to axillae, extremities, the face or the trunk. The diagnosis can be made when sweating exceeds thermoregulatory needs, although the number of apocrine and eccrine glands is not increased (fig. 1). Quality of life and social activities are highly affected and patients seek therapies reducing the amount of sweat (1). For axillary disease, beside deodorants with aluminium salts, usually insufficient in this condition, many different therapeutic solutions have been proposed. Some of them were abandoned due to excessive side effects, toxicity or insufficient efficacy.

Zum Artikel als PDF